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Abstract
Purpose To study the feasibility of automatically identifying normal digital mammography (DM) exams with artificial intelli-
gence (AI) to reduce the breast cancer screening reading workload.
Methods and materials A total of 2652 DM exams (653 cancer) and interpretations by 101 radiologists were gathered from nine
previously performed multi-reader multi-case receiver operating characteristic (MRMCROC) studies. An AI systemwas used to
obtain a score between 1 and 10 for each exam, representing the likelihood of cancer present. Using all AI scores between 1 and 9
as possible thresholds, the exams were divided into groups of low- and high likelihood of cancer present. It was assumed that,
under the pre-selection scenario, only the high-likelihood group would be read by radiologists, while all low-likelihood exams
would be reported as normal. The area under the reader-averaged ROC curve (AUC) was calculated for the original evaluations
and for the pre-selection scenarios and compared using a non-inferiority hypothesis.
Results Setting the low/high-likelihood threshold at an AI score of 5 (high likelihood > 5) results in a trade-off of approximately
halving (− 47%) the workload to be read by radiologists while excluding 7% of true-positive exams. Using an AI score of 2 as
threshold yields a workload reduction of 17% while only excluding 1% of true-positive exams. Pre-selection did not change the
average AUC of radiologists (inferior 95% CI > − 0.05) for any threshold except at the extreme AI score of 9.
Conclusion It is possible to automatically pre-select exams using AI to significantly reduce the breast cancer screening reading
workload.
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Key Points
• There is potential to use artificial intelligence to automatically reduce the breast cancer screening reading workload by
excluding exams with a low likelihood of cancer.
• The exclusion of exams with the lowest likelihood of cancer in screening might not change radiologists’ breast cancer detection
performance.
• When excluding exams with the lowest likelihood of cancer, the decrease in true-positive recalls would be balanced by a
simultaneous reduction in false-positive recalls.
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Abbreviations
AI Artificial intelligence
AUC Area under the curve
BI-RADS Breast imaging reporting and data system
CAD Computer-aided detection
CI Confidence interval
DM Digital mammography
PoM Probability of malignancy
ROC Receiver operating characteristic
Introduction
Population-based screening programs with digital mammog-
raphy (DM) reduce mortality from breast cancer due to the
earlier detection of the disease [1, 2], but their efficiency is
continuously under discussion [3, 4]. False-positive findings
[5] lead to negative effects such as unnecessary workup, par-
ticipant anxiety and reluctance to re-attend screening, as well
as a reduction in cost-effectiveness [6]. On the other hand,
since the program-based sensitivity of screening is approxi-
mately 75% [7], false-negative findings may lead to false re-
assurance and ultimately a delayed cancer detection. One of
the reasons why mammographically visible cancers are
missed is the low prevalence of cancer (approximately, 10
per thousand) in a screening population [8, 9].
Computer-aided detection (CAD) systems to improve
mammography reading have been used since the beginning
of this century. However, so far no study has found any direct
improvement in screening outcomes, likely because of the low
specificity of these traditional CAD systems [10, 11]. The re-
cent breakthrough in artificial intelligence (AI) performance,
based on the use of deep learning algorithms, is now closing
the gap between human and computer performance in many
applications related tomedical imaging [12]. Novel AI systems
may, therefore, be able to improve the performance and effi-
ciency of population-based screening programs [13]. For
mammography evaluation, deep learning–based systems have
demonstrated a stand-alone performance as good as radiolo-
gists [14], as well as a significant improvement of radiologists’
breast cancer detection accuracy when used for decision sup-
port [15]. However, this radiologist-like performance may
enable other uses of AI for mammography evaluation in
screening. Of particular interest are approaches aimed at reduc-
ing workload, considering the increasing scarcity of (breast)
radiologists in some countries [16–18].
In this work, we explore the possibility of using an AI
system to pre-select likely-normal mammograms. This was
done using an AI system that provides an exam-based score
denoting the likelihood of cancer present in the mammogram.
We analyzed the effects on performance of excluding exams
with a low score (i.e., low likelihood of cancer present) from
human reading, which would reduce the screening workload
for radiologists and increase the cancer prevalence in the ac-
tually evaluated images.
Materials and methods
Data and population characteristics
Digital mammograms were collected from nine previously
performed multi-reader multi-case (MRMC) observer studies
[19–26]. The review board at each institution waived local
ethical approval and informed consent or approved the use
of the anonymized patient data for retrospective research.
All the datasets of the MRMC studies were enriched with
exams with cancer. The ground truth, in terms of cancer pres-
ent, benign lesion present, or absence of abnormalities, of each
DM exam, was confirmed by histopathology and/or at least
1 year of follow-up. During each MRMC study, each DM
exam was evaluated by multiple breast radiologists who pro-
vided malignancy scores for each exam (BI-RADS and/or
level of suspicion).
In total, 2654 exams (653 with cancer, 768 with benign
lesions, 1233 normal) and readings by 101 radiologists (52%
from the USA and 48% from Europe) were gathered (yielding
28,296 independent exam interpretations). Approximately,
half the exams were from screening and half from clinical
practice. Detailed information about the tumor histology was
not available. The DM images were acquired with devices
from four different vendors (Siemens Healthineers; Hologic
Inc.; General Electric Healthcare; SectraMamea) across seven
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different countries. Further details of these nine studies have
previously been reported elsewhere [14].
Artificial intelligence system
For this study, we used an AI system dedicated to breast can-
cer detection in DM and digital breast tomosynthesis
(Transpara 1.4.0, Screenpoint Medical BV). The system uses
deep learning convolutional neural networks, feature classi-
fiers, and image analysis algorithms to detect calcifications
and soft tissue lesions in two different modules [14]. Based
on these detected lesions and overall exam appearance, the AI
system assigns an exam-based integer score denoting the like-
lihood that cancer is present in the exam (hereafter AI score,
also known as Transpara Score). This AI score ranges between
1 and 10 (10 means high likelihood that a cancer is present in
the exam). The AI score is calibrated so that approximately the
same number of normal exams (10% of the total) is assigned
to each AI score category. In a population with low prevalence
of cancer (where most exams are normal), such as a screening
population, it may therefore be expected that approximately
10% of the total exams are in each category. In a screening
population, the 10% of exams scored 1 are predicted to have
the lowest risk of harboring cancer (because category 1 has the
lowest incidence of exams with cancer), while the 10% of
exams scored 10 have the highest risk of harboring cancer
(because category 10 contains the largest fraction of exams
with cancer). Since the calibration of the AI score is performed
only with screening mammograms without abnormalities, the
AI score is independent to the composition of the datasets.
However, the fact that all datasets used for this study were
enriched with cancers implies that the found distribution of
AI scores in our study is skewed towards higher numbers,
since it should be expected that cancer cases are not evenly
distributed over AI categories.
The AI system was trained, validated, and tested using an
external database representative of screening containing over
9000 mammograms with cancer (one-third of which are
presented as lesions with calcifications) and 180,000 mammo-
grams without abnormalities. The AI score was also calibrated
with this external database, using only the normal mammo-
grams. The mammograms used in this study have never been
used to train, validate, or test the algorithms. The mammo-
grams originate from devices from four different vendors
(Hologic; Siemens; General Electric; Philips) and institutions
across Europe, USA, and Asia.
Automated pre-selection of cases
For this study, the distribution of the normal exams and those
containing benign or malignant lesions according to the
ground truth was computed as a function of the AI score. To
divide the exams into two groups (excluded and pre-selected
for evaluation), we varied the threshold dividing these two
groups across all possible AI scores, i.e., from 1 to 9.
Consequently, the pre-selection scenarios included exams-to-
be-evaluated as those with scores greater than 1, 2, 3, 4, 5, 6, 7,
8, or greater than 9 (equivalent to only pre-selected category
10). For each threshold, the characteristics of the exams in
both groups were analyzed.
Under the pre-selection scenarios, we assumed that readers
would only evaluate exams in the pre-selected group (high
likelihood of cancer present), whereas exams in the low-
likelihood group would automatically be assigned a Bnormal^
classification.Workload reduction throughout the text is there-
fore expressed in terms of the number of exams that have to be
read by the screening radiologists. Given the calibration of the
AI system, a pre-selection threshold of 5, for instance, means
that half of the exams in a screening program would be ex-
cluded from human reading. An estimation of how radiolo-
gists’ performance would change after pre-selection was cal-
culated by a posteriori modification of the original radiolo-
gists’ scores: for the exams in the excluded group, all the
radiologists’ scores were automatically modified to the lowest
possible value (e.g., 1). This implies that we assumed invari-
ance in human behavior for the pre-selected mammograms
that were above the threshold and therefore should be
evaluated.
Statistics
The breast cancer detection accuracy of radiologists in the
original scenario was compared with the simulated pre-
selection scenario with a non-inferiority null hypothesis
[27–31] based on the differences in the average area under
the receiver operating characteristic curve (AUC). The non-
inferiority margin was set at 0.05 in this study. Non-inferiority
was concluded when the AUC difference Bpre-selection
scenario^ – Boriginal reading^ was greater than 0 and the
lower limit of the 95% confidence interval (CI) of the differ-
ence was greater than the non-inferiority margin. Confidence
intervals were Bonferroni-corrected for multiple comparisons.
To obtain the average AUC across all our data, we used the
public-domain iMRMC software for analysis (version 4.0.0,
Division of Imaging, Diagnostics, and Software Reliability,
OSEL/CDRH/FDA, Silver Spring, MD) [29, 30], which can
handle not fully crossed study designs, such as the split-plot
design resulting when pooling the nine datasets from this
study [32, 33]. The reader-averaged ROC curves were created
by averaging the reader-specific non-parametric (trapezoidal)
curves along lines perpendicular to the chance line [34]. This
average is area-preserving; its AUC is equal to the reader-
averaged non-parametric AUCs. The analysis was not done
per dataset, given the homogeneous performance of the AI
system across datasets seen in Rodriguez-Ruiz et al [14]. We
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therefore assumed that no differences per dataset would be
present in this study.
Results
Performance of the AI system
The distributions of DM exams as a function of AI score are
shown in Fig. 1 (for each type of exam according to ground
truth: a, normal; b, cancer; c, benign). As expected, normal
exams are distributed evenly across AI scoring categories,
with an average of 10.0% of normal exams per category
(range 7.2–14.9%). For the exams containing cancer, 72.5%
are categorized within the highest cancer-present likelihood
category (10), whereas 95.1% lie in the categories 5–10. In
comparison, only 27% of exams containing benign lesions are
in category 10. An example of an exam with cancer that was
assigned a low AI score is shown in Fig. 2.
Automated pre-selection of cases
The proportion and type of exams that would be excluded
from reading after a pre-selection of exams using different
pre-selection thresholds are depicted in Fig. 3. The trade-off
between reducing screening reading workload (e.g., excluding
normal exams) and excluding exams containing cancer from
the reading is shown: halving the workload of screening
(− 47% of screening exams) can be achieved if only exams
with scores higher than 5 are read, at the expense of excluding
7% of cancer exams. With a threshold of 2 for pre-selection,
for instance, only 1% of exams containing cancer are excluded
but the reading workload is reduced by up to 17%.
Simultaneously, these thresholds would reduce the cases con-
taining benign lesions by 27% and 5%, respectively, thus re-
ducing the number of false-positive recalls substantially.
After the pre-selection of exams, assuming invariance of
reader behavior, the average breast cancer detection perfor-
mance (AUC) of the radiologists did not change. The AUC
for the reading of the pre-selection population was non-
inferior to the AUC of the original population. This was sig-
nificant (lowest Bonferroni-corrected 95% CI > − 0.05, AUC
differences were less than 1%, see Fig. 4) for all possible
thresholds except for 9, when only exams in the highest
cancer-present likelihood category (10) would be evaluated
(low 95% CI = − 0.052, AUC decreased by 2%).
Discussion
In this work, we have evaluated the feasibility of using an AI
system to automatically discriminate between screening mam-
mography exams that have a higher and a lower likelihood
that cancer is present. Our study shows that, in some situa-
tions, it could be a possibility to exclude exams with a lower
AI score from human evaluation since the cancer prevalence
in these exams is much lower than in an unselected popula-
tion, thus potentially reducing the reading workload for
radiologists.
Fig. 1 Distribution of normal (a), cancer (b), and benign exams (c) as a
function of AI score, representing the likelihood of cancer present (1–10,
10 means high likelihood of cancer present). The contribution of each
dataset to the overall percentage of exams is shown
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If such a pre-selection scenario is to be considered, our
results point to a trade-off between reducing workload and
risking to exclude exams with cancer, which depends on the
threshold chosen to create the two groups. On the other hand,
the optimal threshold would likely be dependent on local prac-
tices and necessities. With a low threshold, we observed a
relatively safe scenario with an approximate reduction of
17% in workload at the expense of excluding 1% of exams
with cancer from reading (at a cancer detection rate in screen-
ing of approximately 6/1000, the cancer prevalence in this
group would be approximately 0.3 per 1.000). With a thresh-
old set at an AI score of 5, the workload reduction increases to
47%, at an expense of 7% of cancers. Nevertheless, the exams
with cancer in this study do not only originate from screening
but also from clinical practice, and it is reported that some
cancers in the original reader study were detected by other
means such as palpation, ultrasound or breast tomosynthesis
[19–26]. This likely means that the reported percentage of
excluded exams containing cancer in this study might be
overestimating the actual exclusion proportion of screen-
detected cancers. A limitation of our study is that we cannot
analyze the abovementioned results per detection mode
(screening or clinical), per histopathological type of cancers
or per breast density, because this information is not available
from the original studies.
Our results suggest that pre-selection of exams does not
lead to a reduction of the overall detection performance of
radiologists, with the AUC varying by less than 1%. This
supports the theory that cancers missed by AI are also missed
by radiologists, probability due to their low mammographic
visibility.
We assumed invariance in reading of the pre-selectedmam-
mograms. However, in actual screening practice, there might
be several factors affecting radiologists’ scoring of pre-
selected exams. The higher prevalence of cancer in the pre-
selected cohort might lead to a higher sensitivity for breast
cancer, as in practice, it is easier to detect abnormalities when
their frequency is relatively high [8]. Likewise, it would be
Fig. 2 An example of the nine exams in our study that contained cancer
but were assigned an AI score of 1 or 2, the lowest cancer-present likeli-
hood categories. None of the 6 radiologists recalled this exam during the
original MRMC study (read without priors), suggesting that the cancer
visibility with mammography is poor in these exams (and in fact, the
cancer may have been detected by other means)
Fig. 3 Proportion (%) of exams that would be excluded from the final
sample to be evaluated by the radiologists, using all possible AI scores as
thresholds values for pre-selection for reading
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interesting to investigate whether reading the pre-selected
group of mammograms in a specific order, e.g., from higher
to lower AI score, is also of added value (as cancer prevalence
increases with increasing AI score). It would also be possible
to increase the recall rate in the pre-selected cohort on purpose
(by lowering the recall threshold), in order to counter-balance
the exclusion of the cancer-containing mammograms with a
low AI score. The fact that more benign lesions are excluded
likely makes this possible without increasing the overall recall
rate.
The exclusion of cases with benign lesions likely improves
the specificity of screening, thus reducing possible harms as-
sociated with false-positive recalls. The similarity of ROC
curves after exclusion of cases suggest indeed that the nega-
tive effect of dismissing exams with cancer is partially bal-
anced by dismissing also false-positive assessments.
However, it may be assumed that most benign abnormalities
with a relatively lowAI score will be lesions that are classified
as certainly benign by breast radiologists without biopsy;
therefore, the effect on the fraction of women that undergoes
biopsy for benign lesions may be smaller.
While in this study we propose automatic labeling of mam-
mograms that would never be read by human radiologists, an
alternative possibility is to use the automatically created
groups of exams to differentiate cases that need double read-
ing, from cases for which single reading is sufficient. Such a
strategy may be valuable for e.g. European screening pro-
grams, where double reading is a practice, and may be of
special interest for programs that use breast tomosynthesis as
the imaging technique for screening, because of the longer
reading time per case [25, 35]. Obviously, the effects of such
stratification should be further evaluated.
Improvements of the computer system, such as inclusion of
temporal information from prior exams, will presumably fur-
ther enhance the pre-selection, as the current system only uses
information from the current DM exams. Evaluation of other
systems and versions should be regularly performed consider-
ing the rapid speed of evolution in the field of machine learning.
Our study had several limitations. The used datasets were
not obtained from screening, but were enriched with cancer
cases. The exams were not double-read, as is common practice
in screening in Europe, but independently read by multiple
radiologists per case. The mix of screening and clinical data
may have also introduced cancers that have different charac-
teristics from screen-detected cancers, which might bias our
results. Since we have no histological characteristics of the
tumors, we cannot be certain of the impact of the cancers that
were excluded from human reading based upon the AI score
on women’s health. However, because mass screening per se
is a balance between benefits, harms, and costs for the society,
pre-selection of possibly abnormal and definitively normal
cases may be a valid alternative for current screening practice.
Further testing of such a pre-selection scenario in real screen-
ing populations is required to validate our findings in terms of
the effect on recall rates, true-positive and false-positive
screening assessments, and interval cancer rates.
In conclusion, we present a new strategy to reduce the
reading workload in mammography-based breast cancer
screening programs which do not appear to decrease the de-
tection performance of radiologists, by using an AI system to
automatically pre-select exams for radiologist evaluation
while excluding those exams which have a low likelihood of
harboring cancer from human reading.
Acknowledgements The authors would like to thankDr. BrandonGallas,
Dr.Weijie Chen, andMr. Qi Gong (Division of Imaging, Diagnostics, and
Software Reliability, OSEL/CDRH/FDA, Silver Spring, MD, USA) for
their help in implementing the statistical methods of the study with their
iMRMC software (https://github.com/DIDSR/iMRMC). We would also
like to thank all the radiologists involved in the reader studies whose
results were used in this work and ScreenPoint Medical for providing
their software for this research.
Fig. 4 ROC curves (a) and change (b) in AUC values of the average of
radiologists in the original population, as well as in all possible pre-
selected populations (using all possible AI scores as threshold values
for pre-selection for reading; if the case is not pre-selected, the radiologist
score is converted to the lowest possible cancer suspicion score for the
MRMC study). 95% confidence intervals are Bonferroni-corrected
4830 Eur Radiol (2019) 29:4825–4832
Funding The authors state that this work has not received any funding.
Compliance with ethical standards
Guarantor The scientific guarantor of this publication is Ritse Mann.
Conflict of interest The authors of this manuscript declare relationships
with the following companies:
The authors KL, PC, TH, TM, SZ, IS, and RM of this manuscript
declare relationships with Siemens Healthineers (Erlangen, Germany):
TM is an employee, KL, PC, TH, SZ, IS, and RM received research
grants.
The authors AR, AG, and RM declare relationships with ScreenPoint
Medical BV (Nijmegen, Netherlands): AR and AG are employees, RM is
an advisor.
Statistics and biometry Dr. Brandon Gallas, Dr. Weijie Chen, and Mr.
Qi Gong (Division of Imaging, Diagnostics, and Software Reliability,
OSEL/CDRH/FDA, Silver Spring, MD, USA) kindly provided statistical
advice for this manuscript.
One of the authors has significant statistical expertise.
No complex statistical methods were necessary for this paper.
Informed consent Written informed consent was waived by the
Institutional Review Board.
Ethical approval Institutional Review Board approval was obtained.
Study subjects or cohorts overlap Some study subjects or cohorts have
been previously reported in (BStand-alone artificial intelligence for breast
cancer detection in mammography: Comparison with 101 radiologists^
by A. Rodriguez-Ruiz et al 2018, accepted in December 2018, Journal of
the National Cancer Institute).
Methodology
• retrospective
• experimental
• multicenter study
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Smith RA, Cokkinides V, Brooks D, Saslow D, Brawley OW
(2010) Cancer screening in the United States, 2010: a review of
current American Cancer Society guidelines and issues in cancer
screening. CA Cancer J Clin 60:99–119
2. Broeders M, Moss S, Nyström L et al (2012) The impact of mam-
mographic screening on breast cancer mortality in Europe: a review
of observational studies. J Med Screen 19:14–25
3. Independent UK Panel on Breast Cancer Screening (2012) The
benefits and harms of breast cancer screening: an independent re-
view. Lancet 380:1778–1786
4. Welch HG, Prorok PC, O’Malley AJ, Kramer BS (2016) Breast-
cancer tumor size, overdiagnosis, and mammography screening
effectiveness. N Engl J Med 375:1438–1447
5. Breast Cancer Surveillance Consortium (BCSC) Performance mea-
sures for 1,838,372 screening mammography examinations from
2004 to 2008 by age–based on BCSC data through 2009.
National Cancer Institute. Available via http://www.bcsc-research.
org/statistics/performance/screening/2009/perf_age.html. Accessed
29 Sep 2017
6. Brewer NT, Salz T, Lillie SE (2007) Systematic review: the long-
term effects of false-positive mammograms. Ann Intern Med 146:
502–510
7. Karssemeijer N, Bluekens AM, Beijerinck D et al (2009) Breast
cancer screening results 5 years after introduction of digital mam-
mography in a population-based screening program. Radiology
253:353–358
8. Evans KK, Birdwell RL,Wolfe JM (2013) If you don’t find it often,
you often don’t find it: why some cancers are missed in breast
cancer screening. PLoS One 8:e64366
9. Huynh PT, Jarolimek AM, Daye S (1998) The false-negative mam-
mogram. Radiographics 18:1137–1154 quiz 1243-1134
10. Fenton JJ, Taplin SH, Carney PA et al (2007) Influence of
computer-aided detection on performance of screening mammog-
raphy. N Engl J Med 356:1399–1409
11. Lehman CD, Wellman RD, Buist DS et al (2015) Diagnostic accu-
racy of digital screening mammography with and without
computer-aided detection. JAMA Intern Med 175:1828–1837
12. Litjens G, Kooi T, Bejnordi BE et al (2017) A survey on deep
learning in medical image analysis. Med Image Anal 42:60–88
13. Trister AD, Buist DSM, Lee CI (2017) Will machine learning tip
the balance in breast cancer screening? JAMA Oncol. https://doi.
org/10.1001/jamaoncol.2017.0473
14. Rodriguez-Ruiz A, Lång K, Gubern-Merida A et al (2019) Stand-
alone artificial intelligence for breast cancer detection in mammog-
raphy: comparison with 101 radiologists. J Natl Cancer Inst. https://
doi.org/10.1093/jnci/djy222
15. Rodríguez-Ruiz A, Krupinski E,Mordang J-J et al (2018) Detection
of breast cancer with mammography: effect of an artificial intelli-
gence support system. Radiology 181371
16. Rimmer A (2017) Radiologist shortage leaves patient care at risk,
warns royal college. BMJ 359
17. National Health Institutes England, Public Health England, British
Society of Breast Radiology, Royal College of Radiologists (2017)
The breast imaging and diagnostic workforce in the United
Kingdom. Available via https://www.rcr.ac.uk/publication/breast-
imaging-and-diagnostic-workforce-united-kingdom. Accessed 30
Dec 2018
18. Wing P, Langelier MH (2009) Workforce shortages in breast imag-
ing: impact on mammography utilization. Am J Roentgenol 192:
370–378
19. Wallis MG, Moa E, Zanca F, Leifland K, Danielsson M (2012)
Two-view and single-view tomosynthesis versus full-field digital
mammography: high-resolution X-ray imaging observer study.
Radiology 262:788–796
20. Visser R, Veldkamp WJ, Beijerinck D et al (2012) Increase in per-
ceived case suspiciousness due to local contrast optimisation in
digital screening mammography. Eur Radiol 22:908–914
21. Hupse R, Samulski M, Lobbes MB et al (2013) Computer-aided
detection of masses at mammography: interactive decision support
versus prompts. Radiology 266:123–129
22. Gennaro G, Hendrick RE, Ruppel P et al (2013) Performance com-
parison of single-view digital breast tomosynthesis plus single-view
digital mammography with two-view digital mammography. Eur
Radiol 23:664–672
23. Siemens Medical Solutions USA Inc (2015) FDA Application:
Mammomat Inspiration with Digital Breast Tomosynthesis.
Available via https://www.accessdata.fda.gov/cdrh_docs/pdf14/
P140011b.pdf. Accessed March 3 2018
Eur Radiol (2019) 29:4825–4832 4831
24. Garayoa J, Chevalier M, CastilloM et al (2018) Diagnostic value of
the stand-alone synthetic image in digital breast tomosynthesis ex-
aminations. Eur Radiol 28:565–572
25. Rodriguez-Ruiz A, Gubern-Merida A, Imhof-Tas M et al (2017)
One-view digital breast tomosynthesis as a stand-alone modality
for breast cancer detection: do we need more? Eur Radiol. https://
doi.org/10.1007/s00330-017-5167-3
26. Clauser P, Baltzer PA, Kapetas P et al (2019) Synthetic 2-
dimensional mammography can replace digital mammography as
an adjunct to wide-angle digital breast tomosynthesis. Invest Radiol
54:83–88
27. Blackwelder WC (1982) BProving the null hypothesis^ in clinical
trials. Control Clin Trials 3:345–353
28. Chen W, Petrick NA, Sahiner B (2012) Hypothesis testing in non-
inferiority and equivalence MRMC ROC studies. Acad Radiol 19:
1158–1165
29. Gallas BD, Bandos A, Samuelson FW,Wagner RF (2009) A frame-
work for random-effects ROC analysis: biases with the bootstrap
and other variance estimators. Commun Stat - Theory Methods 38:
2586–2603
30. Gallas B (2017) iMRMC v4.0: application for analyzing and sizing
MRMC reader studies. Division of imaging, diagnostics, and
software reliability, OSEL/CDRH/FDA, Silver Spring, MD.
Available via https://github.com/DIDSR/iMRMC/releases, https://
cran.r-project.org/web/packages/iMRMC/index.html. Accessed 30
Dec 2018
31. Gennaro G (2018) The Bperfect^ reader study. Eur J Radiol In press
32. ChenW, Gong Q, Gallas BD (2018) Efficiency gain of paired split-
plot designs inMRMCROC studies. Medical imaging 2018: image
perception, observer performance, and technology assessment.
International Society for Optics and Photonics, pp 105770F
33. Gallas BD, BrownDG (2008) Reader studies for validation of CAD
systems. Neural Netw 21:387–397
34. Chen W, Samuelson FW (2014) The average receiver operating
characteristic curve in multireader multicase imaging studies. Br J
Radiol 87:20140016
35. Dang PA, Freer PE, Humphrey KL, Halpern EF, Rafferty EA
(2014) Addition of tomosynthesis to conventional digital mam-
mography: effect on image interpretation time of screening exam-
inations. Radiology 270:49–56
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
4832 Eur Radiol (2019) 29:4825–4832
